BioInvent International
0 followers
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment... Read more
Org chart
Martin Welschof
Chief Executive Officer
Martin Welschof
Collapse
Marie Moores
Chief Operating Officer
Björn Frendéus
Chief Scientific Officer
Stefan Ericsson
Chief Financial Officer
Andres Mcallister
Chief Medical Officer
Sylvie Ryckebusch
Chief Business Officer
Ingunn Munch Lindvig
SVP, Regulatory Affairs
Ingrid Teige
Vice President Preclinical
Maria Stenbäck
VP Intellectual Property
Emma Meurling
Human Resources Director
Teams
View all
